onclive· 2mo ago
save<![CDATA[Emerging Biomarkers in NSCLC: TROP2 Scoring and MTAP Loss]]>
May 14, 2026read original ↗
<![CDATA[How Trop2 and MTAP-loss reshape NSCLC therapy, with AI pathology refining ADC response prediction and guiding trial referrals.]]>
The original article is no longer reachable from this URL.
read full article on onclive ↗🔗 mentioned in this article
no entities indexed yet
comments(0)
5-min edit window · permanent after that